Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TENOFOVIR ALAFENAMIDE vs TEPLIZUMAB-MZWV: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TENOFOVIR ALAFENAMIDE vs TEPLIZUMAB-MZWV: Safety Overview

Metric TENOFOVIR ALAFENAMIDE TEPLIZUMAB-MZWV
Total FAERS Reports 2,990 395
Deaths Reported 311 0
Death Rate 10.4% N/A
Hospitalizations 713 13
Average Patient Age 58.6 yrs 30.5 yrs
% Female Patients 39.3% 58.2%
FDA Approval Date Mar 21, 2024 N/A
Manufacturer Gilead Sciences, Inc. N/A
Route ORAL N/A
Marketing Status Prescription Prescription